(d) Compound 1b.
carboxylphenyl
A
solution of 2¢,6¢-dimethyl-4¢-
fractions containing product 3b were combined, frozen at -80 ◦C
and lyophilized to dryness to a yellow, fluffy powder. Yield =
28.7 mg (50%); dH (500 MHz, CF3COOD) 2.27 (br m, 4 H), 2.44
(br s, 2 H), 2.62 (s, 8 H), 2.71 (br s, 2 H), 2.87 (br s, 2 H), 3.03
(br s, 2 H), 3.13 (s, 4 H), 3.26 (s, 3 H), 3.50 (br s, 2 H), 3.64 (m,
6 H), 3.83 (br s, 4 H), 3.91 (br s, 2 H), 5.94 (br t, 2 H), 7.78 (s, 2
H), 8.21 (t, 2 H), 8.63 (t, 2 H), 8.82 (d, 2 H, J = 8.6), 9.00 (d, 2
H, J = 8.9); dC (125 MHz, CF3COOD) 16.3, 17.7, 19.8, 20.1, 22.1,
23.1, 24.5, 24.9, 29.1, 31.9, 33.8, 37.4, 47.5, 48.2, 50.1, 60.0, 60.2,
118.3, 123.4, 124.9, 127.9, 128.5, 129.4, 130.6, 131.9, 140.4, 141.5,
148.7, 151.5, 168.8, 173.9, 176.7, 177.5, 180.2; MALDI-TOF MS
m/z 955.2 (M + H)+; HRMS m/z 954.3274 (M + H)+ (954.3265
calculated).
N-sulfopropylacridinium-9-carboxylate2,5
(30 mg, 0.061 mmole) in DMF (3 mL) was treated with diiso-
propylethylamine (0.016 mL, 0.0917 mmole, 1.5 equivalents)
and N,N,N¢,N¢-tetramethyl-O-(N-succinimidyl)uronium tetraflu-
oroborate (TSTU) (22 mg, 0.0732 mmol, 1.2 equivalents). The
reaction was stirred at room temperature. After 15 min, HPLC
analysis of a small portion of the reaction mixture was performed
using a Phenomenex, 10 micron, C18 3.9 mm ¥ 25 cm column and
a 30 min gradient of 10 → 70% B (A = water with 0.05% TFA,
B = MeCN with 0.05% TFA) at a flow rate of 1.0 mL min-1 and
UV detection at 260 nm. Product NHS ester (compound v) was
observed eluting at 20 min and was the major component. This
DMF solution of the NHS ester, compound v, was added dropwise
to a solution of N,N-bis(3-aminopropyl)methylammonium-1,3-
propane sulfonate, compound iv, (0.136 g, 0.0304 mmol, 5
equivalents, HBr salt) dissolved in DMF (1 mL) and 0.25 M
sodium bicarbonate (1 mL). The reaction was stirred at room
temperature. After 3 h, HPLC analysis showed clean conversion
to the product 1b, eluting at 12.4 min. Using a 40 min gradient of
10 → 40% B (A = water with 0.05% TFA, B = MeCN with 0.05%
TFA), the product eluted at 19.2 min. The product was purified
by preparative HPLC using a YMC, 10 micron, C18 30 ¥ 250 mm
column and 40 min gradient of 10 → 40% B (A = water with
0.05% TFA, B = MeCN with 0.05% TFA) at a solvent flow rate of
20 mL min-1 and UV detection at 260 nm. The HPLC fractions
containing product 1b were combined and concentrated under
reduced pressure to yield a yellow, sticky solid. Yield = 45 mg
(86%, TFA salt); dH (500 MHz, CF3COOD) 2.40 (br s, 2 H), 2.56
(br s, 10 H), 2.95 (br s, 2 H), 3.24 (s, 3 H), 3.46 (br t, 4 H), 3.65
(br s, 4 H), 3.72–3.86 (br m, 6 H), 5.87 (br t, 2 H), 7.71 (s, 2 H),
8.15 (t, 2 H), 8.57 (t, 2 H), 8.76 (d, 2 H, J = 8.6), 8.92 (d, 2 H, J =
9.1); dC (125 MHz, CF3COOD) 16.3, 17.7, 20.2, 22.2, 23.2, 37.4,
37.8, 47.4, 48.1, 48.2, 50.0, 59.1, 60.1, 60.9, 118.3, 123.4, 124.9,
127.9, 128.4, 129.5, 130.6, 131.9, 140.5, 141.5, 148.8, 151.5, 171.8;
MALDI-TOF MS m/z 743.2 (M + H)+; HRMS m/z 743.2786
(M + H)+ (743.2784 calculated).
(f) Theophylline conjugate 2b.
A
solution of com-
pound 1b (22 mg, 0.0257 mmol, TFA salt) in DMSO
(2 mL) was added to 8-carboxypropyltheophylline (5.5 mg,
0.0207 mmol, Sigma) followed by diisopropylethylamine
(0.0088 mL, 0.0505 mmol, 2 equivalents) and (benzotriazol-
1-yl-oxy)tris(dimethylamino)phosphonium hexafluorophosphate
(BOP) (13.7 mg, 0.031 mmol, 1.2 equivalents). The reaction was
stirred at room temperature for 16 h and then analyzed by HPLC
using a Phenomenex, 10 micron, C18 3.9 mm ¥ 25 cm column
and a 40 min gradient of 10 → 40% B (A = water with 0.05%
TFA, B = MeCN with 0.05% TFA) at a flow rate of 1.0 mL min-1
and UV detection at 260 nm. Product was observed eluting at
23.6 min and was the major component. The product was purified
by preparative HPLC using a YMC, 10 micron, C18 30 ¥ 250 mm
column and 40 min gradient of 10 → 40% B (A = water with
0.05% TFA, B = MeCN with 0.05% TFA) at a solvent flow
rate of 20 mL min-1 and UV detection at 260 nm. The HPLC
fractions containing product 2b were combined, frozen at -80 ◦C
and lyophilized to dryness to a yellow, fluffy powder. Yield = 7.5 mg
(37%); dH (500 MHz, CF3COOD) 2.36 (br s, 2 H), 2.50 (br s, 4 H),
2.62 (br s, 2 H), 2.67 (s, 6 H), 2.79 (br s, 2 H), 3.06 (m, 2 H), 3.30
(s, 3 H), 3.46 (t, 2 H, J = 7.8), 3.51 (t, 2 H, J = 7.2), 3.65 (br s, 4
H), 3.70 (s, 3 H), 3.81–3.89 (m, 4 H), 3.91 (s, 3 H), 3.94 (t, 2 H, J =
6.4), 5.99 (m, 2 H), 7.82 (s, 2 H), 8.25 (t, 2 H), 8.67 (t, 2 H), 8.87 (d,
2 H, J = 8.6), 9.04 (d, 2 H, J = 9.5); MALDI-TOF MS m/z 992.0
(M + H)+; HRMS m/z 991.3680 (M + H)+ (991.3694 calculated).
(e) Compound 3b. A solution of compound 1b (45 mg,
0.0525 mmol) in methanol (3.6 mL) and water (0.4 mL) was
treated with diisopropylethylamine (0.053 mL, 0.303 mmol, 5.8
equivalents) and glutaric anhydride (34.5 mg, 0.303 mmol, 5.8
equivalents). The reaction was stirred at room temperature. After
15 min, HPLC analysis of a small portion of the reaction mixture
was performed using a Phenomenex, 10 micron, C18 3.9 mm ¥
25 cm column and a 30 min gradient of 10 → 70% B (A = water
with 0.05% TFA, B = MeCN with 0.05% TFA) at a flow rate of
1.0 mL min-1 and UV detection at 260 nm. The glutarate derivative
was observed eluting at 14 min and was the major component. The
solvent was then removed under reduced pressure. The residue
was dissolved in DMF (3.6 mL) and water (0.4 mL). This solution
was treated with diisopropylethylamine (0.106 mL, 10 equivalents)
and TSTU (182 mg, 10 equivalents). The reaction was stirred at
room temperature. After 10 min, HPLC analysis showed complete
conversion to the product 3b eluting at 15.3 min. The product was
purified by preparative HPLC using a YMC, 10 micron, C18 30 ¥
250 mm column and 40 min gradient of 10 → 40% B (A = water
with 0.05% TFA, B = MeCN with 0.05% TFA) at a solvent flow
rate of 20 mL min-1 and UV detection at 260 nm. The HPLC
General procedure for protein labeling with acridinium esters
Three proteins were used for labeling with the acridinium ester
labels 3a and 3b; a murine anti-TSH monoclonal antibody with
an acidic pI = 5.6 (TSH = Thyroid Stimulating Hormone), a murine
anti-HBsAg monoclonal antibody with a neutral pI = 7 (HBsAg =
Hepatitis B Surface Antigen) and egg white avidin, pI = 10.5. The
following is a typical procedure for labeling the three proteins with
10 equivalents input of acridinium ester label.
The anti-TSH murine monoclonal antibody (1 mg, 6.67
nanomoles, stock solution 5 mg mL-1, 0.2 mL) was diluted with
0.2 mL of 0.1 M sodium carbonate, pH 9. The protein solution
was treated with DMSO solutions of acridinium esters as follows:
for labeling with 10 equivalents of 3a, 0.0129 mL of a 5 mg mL-1
DMSO solution of the compound was added and, for labeling
with 10 equivalents of compound 3b, 0.0127 mL of a 5 mg mL-1
D◦MF solution was added. The labeling reactions were stirred at
4 C for 16 h and were then transferred to 4 mL AmiconTM filters
(MW 30 000 cutoff) and diluted with 3.5 mL de-ionized water.
This journal is
The Royal Society of Chemistry 2011
Org. Biomol. Chem., 2011, 9, 5092–5103 | 5101
©